Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement
暂无分享,去创建一个
B. Baca | S. Erdamar | B. Gürses | T. Attila | N. Beşe | E. Esen | E. Aytaç | I. Hamzaoglu | T. Karahasanoğlu | U. Özbek | B. Erkol | B. Çil | N. Tözün | Y. Kapran | Volkan Özben | M. Saruç | U. Selek | E. Balik | D. Bugra | E. Vardareli | Ö. Er | O. Bilge | B. Baran | Kemal Ünal | Y. Bölükbaşı | C. Yakicier | C. Aygün | L. Güner | Emre Özoran | N. Molinas Mandel | B. O. Uluç | T. Yalti | Leyla Özer | O. Cığ Taşkın | Mehmet Ufuk Abacıoğlu | Murat Gönenç | Mehmet Erdem Yıldız | Güralp Onur Ceyhan | Hülya Kayserili Karabey | The İstanbul Group | B. Uluç | Burçak Erkol | D. Buğra | E. Özoran
[1] L. Diaz,et al. Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406). , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. Steele,et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. , 2020, Diseases of the colon and rectum.
[3] T. Conroy,et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. , 2020, Journal of Clinical Oncology.
[4] V. Heinemann,et al. FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109). , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Hein Putter,et al. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Aparicio,et al. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018) , 2018, Clinical and Translational Oncology.
[7] I. Endo,et al. Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis , 2018, Annals of Surgical Oncology.
[8] B. Yaremko,et al. Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial , 2018, International Journal of Radiation Oncology*Biology*Physics.
[9] J. Torkington,et al. Protocol for a multicentre, dual prospective and retrospective cohort study investigating timing of ileostomy closure after anterior resection for rectal cancer: The CLOSurE of Ileostomy Timing (CLOSE-IT) study , 2018, BMJ Open.
[10] Hongtu Zheng,et al. A negative‐doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer , 2018, Journal of surgical oncology.
[11] W. Bacorro,et al. Neoadjuvant Radiotherapy Versus No Radiotherapy for Stage IV Rectal Cancer: a Systematic Review and Meta-analysis , 2018, Journal of Gastrointestinal Cancer.
[12] D. Winter,et al. Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer , 2018, BJS open.
[13] E. Aly,et al. ‘Watch and wait’ in rectal cancer: summary of the current evidence , 2018, International Journal of Colorectal Disease.
[14] Ahmed Kamel,et al. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[15] P. Lønning,et al. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer , 2018, JAMA surgery.
[16] M. Pocard,et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. , 2018, Journal of Clinical Oncology.
[17] P. Haywood,et al. Cost‐effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model , 2018, ANZ journal of surgery.
[18] C. Flowers,et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.
[19] T. Pawlik,et al. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. , 2018, Surgical oncology.
[20] T. Pawlik,et al. The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases , 2018, Journal of Gastrointestinal Surgery.
[21] H. Lang,et al. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy in the Treatment of Colorectal Liver Metastases: Current Scenario , 2018, Digestive Surgery.
[22] H. Ueno,et al. Prominent Information of jN3 Positive in Stage III Colorectal Cancer Removed by D3 Dissection: Retrospective Analysis of 6866 Patients From a Multi-institutional Database in Japan , 2018, Diseases of the colon and rectum.
[23] G. Fontanini,et al. Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial , 2018, JAMA oncology.
[24] A. Santoro,et al. Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? , 2018, Annals of Surgical Oncology.
[25] J. Marshall,et al. Does stereotactic body radiation therapy have a role in oligoprogressive metastatic colorectal cancer , 2018 .
[26] A. Tanaka,et al. Comparisons of Rigid Proctoscopy, Flexible Colonoscopy, and Digital Rectal Examination for Determining the Localization of Rectal Cancers , 2018, Diseases of the colon and rectum.
[27] Sheraz Yaqub,et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial , 2018, Annals of surgery.
[28] J. Shindoh,et al. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors , 2018, Journal of surgical oncology.
[29] K. Sheahan,et al. Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens , 2018, Journal of Clinical Pathology.
[30] Stuart A. Taylor,et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2018, European Radiology.
[31] W. Frankel,et al. Immunohistochemical Pitfalls: Common Mistakes in the Evaluation of Lynch Syndrome. , 2017, Surgical pathology clinics.
[32] M. Sajid,et al. Early vs delayed closure of loop defunctioning ileostomy in patients undergoing distal colorectal resections: an integrated systematic review and meta‐analysis of published randomized controlled trials , 2017, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[33] S. Park,et al. Restaging Abdominopelvic Computed Tomography Before Surgery After Preoperative Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer , 2017, JAMA oncology.
[34] T. Pawlik,et al. Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis , 2017, Annals of surgery.
[35] C. V. D. van de Velde,et al. Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique , 2017, Clinics in Colon and Rectal Surgery.
[36] G. S. São Julião,et al. Local Excision and Endoscopic Resections for Early Rectal Cancer , 2017, Clinics in Colon and Rectal Surgery.
[37] Stuart A. Taylor,et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2017, European Radiology.
[38] S. Ishihara,et al. Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal Cancer—Predictive Factors and Prognosis , 2017, Clinical colorectal cancer.
[39] G. Beets,et al. Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. , 2017, European journal of radiology.
[40] V. Heinemann,et al. mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109). , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] B. Isaksson,et al. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis , 2017, Annals of surgery.
[42] J. Desai,et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. , 2017, The Lancet. Oncology.
[43] V. Gebski,et al. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials , 2017, The Lancet. Oncology.
[44] T. Ajithkumar,et al. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review. , 2017, International journal of radiation oncology, biology, physics.
[45] David Lieberman,et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.
[46] N. Baxter,et al. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. , 2017, The lancet. Gastroenterology & hepatology.
[47] S. Barni,et al. FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis , 2017, JAMA oncology.
[48] Stuart A. Taylor,et al. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Diagnosis, Investigations and Screening , 2017, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[49] K. Havenga,et al. Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study , 2017, Annals of Surgical Oncology.
[50] D. Tait,et al. The selection process can improve the outcome in locally advanced and recurrent colorectal cancer: activity and results of a dedicated multidisciplinary colorectal cancer centre , 2017, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[51] M. Mortensen,et al. Intraoperative Ultrasound as a Screening Modality for the Detection of Liver Metastases during Resection of Primary Colorectal Cancer - A Systematic Review , 2017, Ultrasound International Open.
[52] T. Pawlik,et al. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review , 2017, Journal of Gastrointestinal Surgery.
[53] G. Chang,et al. Nonoperative Management or ‘Watch and Wait’ for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal , 2017, Annals of Surgical Oncology.
[54] J. Ledermann,et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial , 2017, Journal of the National Cancer Institute.
[55] E. Kuipers,et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative , 2017, United European gastroenterology journal.
[56] R. Ramsay,et al. Outcome and Salvage Surgery Following “Watch and Wait” for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review , 2017, Diseases of the colon and rectum.
[57] H. Johansson,et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. , 2017, The Lancet. Oncology.
[58] Robyn L. Temple-Smolkin,et al. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] J. E. Jansen,et al. Early Closure of a Temporary Ileostomy in Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial , 2017, Annals of surgery.
[60] M. Haddock. Intraoperative radiation therapy for colon and rectal cancers: a clinical review , 2017, Radiation Oncology.
[61] E. Polo,et al. SEOM Clinical Guideline of localized rectal cancer (2016) , 2016, Clinical and Translational Oncology.
[62] Junhong Han,et al. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial , 2016, Trials.
[63] Min Jung Kim,et al. Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection , 2016, Medicine.
[64] M. Schaeffer,et al. Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations† , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[65] R. Golfieri,et al. Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies , 2016, Liver Cancer.
[66] Jiahong Dong,et al. Comparison of Anatomical and Nonanatomical Hepatectomy for Colorectal Liver Metastasis: A Meta-Analysis of 5207 Patients , 2016, Scientific Reports.
[67] Geerard L Beets,et al. Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis. , 2016, AJR. American journal of roentgenology.
[68] J Ricke,et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[69] Yuhree Kim,et al. Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases , 2016, Journal of Gastrointestinal Surgery.
[70] M. Haddock. Irradiation of Very Locally Advanced and Recurrent Rectal Cancer. , 2016, Seminars in radiation oncology.
[71] A. Nesbakken,et al. National Early Rectal Cancer Treatment Revisited , 2016, Diseases of the colon and rectum.
[72] A. Takeda,et al. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions , 2016, Journal of radiation research.
[73] M. Phipps,et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.
[74] M. Arends,et al. Molecular pathological classification of colorectal cancer , 2016, Virchows Archiv.
[75] E. Ruffini,et al. Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery. , 2016, Journal of thoracic disease.
[76] B. Vogelstein,et al. Programmed death-1 blockade in mismatch repair deficient colorectal cancer. , 2016 .
[77] J. Meyerhardt,et al. Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance). , 2016 .
[78] M. A. van den Bosch,et al. The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review , 2016, Clinical and Translational Imaging.
[79] P. Quirke,et al. Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study , 2016, Annals of surgery.
[80] G. Torzilli,et al. Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort , 2016, Annals of Surgical Oncology.
[81] S. McGuire. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. , 2016, Advances in nutrition.
[82] R. Low. Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. , 2016, Journal of gastrointestinal oncology.
[83] M. Baltatzis,et al. Colorectal cancer with synchronous hepatic metastases: Systematic review of reports comparing synchronous surgery with sequential bowel-first or liver-first approaches. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[84] A. Nagatsu,et al. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases , 2016, Annals of Surgical Oncology.
[85] Gina Brown,et al. Systematic review of prognostic importance of extramural venous invasion in rectal cancer. , 2016, World journal of gastroenterology.
[86] Debashis Sahoo,et al. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. , 2016, The New England journal of medicine.
[87] L. Påhlman,et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2015, Cancer treatment reviews.
[88] R. Beart,et al. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial. , 2015, Journal of the National Cancer Institute.
[89] Y. Niv,et al. Immunohistochemistry staining for mismatch repair proteins: the endoscopic biopsy material provides useful and coherent results. , 2015, Human pathology.
[90] T. Crocenzi,et al. Randomized controlled trial of irinotecan drug‐eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver‐limited metastasis , 2015, Cancer.
[91] G. Fontanini,et al. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. , 2015, The Lancet. Oncology.
[92] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[93] William R Jarnagin,et al. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? , 2015, Annals of surgery.
[94] K. Tatsch,et al. Liver resection after selective internal radiotherapy (SIRT): Proof of concept, initial survival, and safety , 2015, Journal of surgical oncology.
[95] Y. Panis,et al. When is the best time for temporary stoma closure in laparoscopic sphincter-saving surgery for rectal cancer? A study of 259 consecutive patients , 2015, Techniques in Coloproctology.
[96] A. Kaiser,et al. The American Society of Colon and Rectal Surgeons' Clinical Practice Guideline for the Treatment of Fecal Incontinence. , 2015, Diseases of the colon and rectum.
[97] M. Wiese,et al. Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer , 2015, British Journal of Cancer.
[98] Myeong-Jin Kim,et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer , 2015, European Radiology.
[99] R. Low,et al. Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures , 2015, Annals of Surgical Oncology.
[100] Jacob Rosenberg,et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. , 2015, The New England journal of medicine.
[101] R. McLeod,et al. Optimisation of preoperative assessment in patients diagnosed with rectal cancer. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).
[102] A. Ejaz,et al. Intraoperative Surgical Margin Re-resection for Colorectal Liver Metastasis: Is It Worth the Effort? , 2015, Journal of Gastrointestinal Surgery.
[103] Claudia Maggi,et al. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis. , 2015, European journal of cancer.
[104] S. Truant,et al. Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[105] H. Wasan,et al. A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof. , 2015, Future oncology.
[106] Marianne Grønlie Guren,et al. Reirradiation of locally recurrent rectal cancer: a systematic review. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[107] M. Flens,et al. The localisation of cancer in the sigmoid, rectum or rectosigmoid junction using endoscopy or radiology-What is the most accurate method? , 2014, Journal of gastrointestinal oncology.
[108] Y. Niv,et al. How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation? , 2014, Human pathology.
[109] W. Kremers,et al. A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection , 2014, Journal of Gastrointestinal Surgery.
[110] B. Edwin,et al. Margin status after laparoscopic resection of colorectal liver metastases: does a narrow resection margin have an influence on survival and local recurrence? , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[111] I. Nagtegaal,et al. Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies , 2014, Clinical Cancer Research.
[112] Bong-Hyeon Kye,et al. Overview of Radiation Therapy for Treating Rectal Cancer , 2014, Annals of coloproctology.
[113] C. Hassan,et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline , 2014, Endoscopy.
[114] T. Holm,et al. Local control and survival after extralevator abdominoperineal excision for locally advanced or low rectal cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[115] A. Lam,et al. Synchronous colorectal cancer: clinical, pathological and molecular implications. , 2014, World journal of gastroenterology.
[116] R. McLeod,et al. Development and Implementation of a Synoptic MRI Report for Preoperative Staging of Rectal Cancer on a Population-Based Level , 2014, Diseases of the colon and rectum.
[117] T. Hickish,et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. , 2014, The Lancet. Oncology.
[118] W. Hohenberger,et al. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria , 2014, The British journal of surgery.
[119] S. Dymarkowski,et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT , 2014, European Radiology.
[120] Yan-Nan Bai,et al. Laparoscopic hepatectomy for liver metastases from colorectal cancer: a meta-analysis. , 2014, Journal of laparoendoscopic & advanced surgical techniques. Part A.
[121] Z. Hamady,et al. One-Millimeter Cancer-Free Margin Is Curative for Colorectal Liver Metastases: A Propensity Score Case-Match Approach , 2014, Annals of surgery.
[122] Zongguang Zhou,et al. Laparoscopic versus Open Hepatectomy with or without Synchronous Colectomy for Colorectal Liver Metastasis: A Meta-Analysis , 2014, PloS one.
[123] S. Fosså,et al. Palliative pelvic radiotherapy of symptomatic incurable rectal cancer – a systematic review , 2013, Acta oncologica.
[124] J. Balmaña,et al. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[125] B. Li,et al. Laparoscopic liver resection as a safe and efficacious alternative to open resection for colorectal liver metastasis: a meta-analysis , 2013, BMC Surgery.
[126] J. Stoker,et al. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. , 2013, Radiology.
[127] C. Haglund,et al. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update , 2013, International journal of cancer.
[128] Reiko Nishihara,et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. , 2013, Journal of the National Cancer Institute.
[129] H. Adami,et al. Current status of screening for colorectal cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[130] John A. Evans,et al. Role of endoscopy in the staging and management of colorectal cancer. , 2013, Gastrointestinal endoscopy.
[131] M. Scorsetti,et al. Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial. , 2013, International journal of radiation oncology, biology, physics.
[132] C. Hassan,et al. Optimal bowel cleansing for colonoscopy: split the dose! A series of meta-analyses of controlled studies. , 2013, Gastrointestinal endoscopy.
[133] Jeffrey J Meyer,et al. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012. (5) , 2013 .
[134] A. Luciani,et al. Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[135] F. Izzo,et al. Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial , 2013, British Journal of Cancer.
[136] J. Matthews,et al. Intraoperative margin re-resection for colorectal cancer liver metastases. , 2013, Hepatobiliary surgery and nutrition.
[137] J. Sagar,et al. Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis. , 2013, Surgical oncology.
[138] L. Capussotti,et al. Comparison of laparoscopic and open intraoperative ultrasonography for staging liver tumours , 2013, The British journal of surgery.
[139] I. Leitman,et al. Strategies to Evaluate Synchronous Carcinomas of the Colon and Rectum in Patients That Present for Emergent Surgery , 2013, International journal of surgical oncology.
[140] C. Combescure,et al. Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis , 2013, Annals of Surgical Oncology.
[141] D. Jayne,et al. Long‐term follow‐up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer , 2013, The British journal of surgery.
[142] M. Gonen,et al. Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer , 2012, Cancer.
[143] D. Goldstein,et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[144] Douglas K Rex,et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.
[145] Shung-Haur Yang,et al. Concurrent Chemoradiotherapy Followed by Metastasectomy Converts to Survival Benefit in Stage IV Rectum Cancer , 2012, Journal of Gastrointestinal Surgery.
[146] B. Yaremko,et al. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial , 2012, BMC Cancer.
[147] R. Glynne-Jones,et al. Critical appraisal of the ‘wait and see’ approach in rectal cancer for clinical complete responders after chemoradiation , 2012, The British journal of surgery.
[148] G. Pond,et al. Fertility risk discussions in young patients diagnosed with colorectal cancer. , 2012, Current oncology.
[149] P. Kienle,et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. , 2012, The Lancet. Oncology.
[150] V. Sehgal,et al. PTU-263 Is it time for gastroenterology and general medicine to go their separate ways? , 2012, Gut.
[151] W. Hohenberger,et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[152] V. Catalano,et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. , 2012, Anticancer research.
[153] Harmeet Kaur,et al. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.
[154] Xavier Dray,et al. Colon cancer: comprehensive evaluation with 64-section CT colonography using water enema as intraluminal contrast agent-a pictorial review. , 2012, Clinical imaging.
[155] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer , 2012, International Journal of Clinical Oncology.
[156] T. Perneger,et al. Survival after Lung Metastasectomy in Colorectal Cancer Patients with Previously Resected Liver Metastases , 2012, World Journal of Surgery.
[157] Joseph Beyene,et al. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis , 2012, Annals of Surgical Oncology.
[158] Jiamei Yang,et al. Anatomical versus nonanatomical resection of colorectal liver metastases: a meta-analysis , 2012, International Journal of Colorectal Disease.
[159] Y. Cho,et al. Optimal Number of Endoscopic Biopsies in Diagnosis of Advanced Gastric and Colorectal Cancer , 2011, Journal of Korean medical science.
[160] Hein Putter,et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. , 2011, The Lancet. Oncology.
[161] Steve Halligan,et al. Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis. , 2011, Radiology.
[162] M. Ychou,et al. Intra-operative radiotherapy of rectal cancer: results of the French multi-institutional randomized study. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[163] T. Fitzgerald,et al. Pushing the envelope beyond a centimeter in rectal cancer: Oncologic implications of close but negative margins. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[164] N. Mangat,et al. Proforma-based reporting in rectal cancer , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.
[165] K. Keum,et al. The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study , 2010, Radiation oncology.
[166] E. Van Cutsem,et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[167] T. Gotoda,et al. Our perspective on endoscopic resection for colorectal neoplasms. , 2010, Gastroenterologie clinique et biologique.
[168] S. Curley,et al. Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases , 2010, Annals of Surgical Oncology.
[169] J. Skibber,et al. Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer , 2010, Annals of Surgical Oncology.
[170] L. Påhlman,et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[171] H. Friess,et al. Does a Rectal Cancer of the Upper Third Behave More Like a Colon or a Rectal Cancer? , 2010, Diseases of the colon and rectum.
[172] A. Bardelli,et al. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[173] E. Kuipers,et al. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory , 2009, Journal of cellular and molecular medicine.
[174] B. Colleypriest,et al. What is the optimal number of biopsies to diagnose a tumor found during colonoscopy? , 2009, Journal of clinical gastroenterology.
[175] A. Bardelli,et al. Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer , 2009, Journal of the National Cancer Institute.
[176] R. Low,et al. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. , 2009, AJR. American journal of roentgenology.
[177] Y. Sano,et al. Size does not determine the grade of malignancy of early invasive colorectal cancer. , 2009, World journal of gastroenterology.
[178] V. Rusch,et al. Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. , 2009, The Annals of thoracic surgery.
[179] J. Monson,et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial , 2009, The Lancet.
[180] J. Monson,et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial , 2009, The Lancet.
[181] J. Monson,et al. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer , 2009, The British journal of surgery.
[182] M. Antunes,et al. Lung metastases from colorectal cancer: surgical resection and prognostic factors. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[183] H. Putter,et al. A Comparison Between the Treatment of Low Rectal Cancer in Japan and the Netherlands, Focusing on the Patterns of Local Recurrence , 2009, Annals of surgery.
[184] M. Ligtenberg,et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer , 2009, British Journal of Cancer.
[185] Dongsheng Tu,et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. , 2008, The New England journal of medicine.
[186] R. Labianca,et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[187] Lars Påhlman,et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[188] P. Quirke,et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[189] D. Parés,et al. Investigation to predict faecal continence in patients undergoing reversal of a defunctioning stoma (Porridge enema test) , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[190] Seung-Yong Jeong,et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[191] R. Glynne-Jones,et al. Complete Clinical Response After Preoperative Chemoradiation in Rectal Cancer: Is a “Wait and See” Policy Justified? , 2008, Diseases of the colon and rectum.
[192] N. Habib,et al. Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis , 2008, Annals of surgery.
[193] H. Putter,et al. The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma , 2007, Annals of surgery.
[194] Sung Ho Moon,et al. Lateral Lymph Node Metastasis Is a Major Cause of Locoregional Recurrence in Rectal Cancer Treated with Preoperative Chemoradiotherapy and Curative Resection , 2007, Annals of Surgical Oncology.
[195] N. Bagla,et al. Rectosigmoid tumours: should we continue sitting on the fence? , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[196] R. Sjödahl,et al. Defunctioning Stoma Reduces Symptomatic Anastomotic Leakage After Low Anterior Resection of the Rectum for Cancer: A Randomized Multicenter Trial , 2007, Annals of surgery.
[197] J. Gurney,et al. Diffusion‐weighted MRI (DWI) in the oncology patient: Value of breathhold DWI compared to unenhanced and gadolinium‐enhanced MRI , 2007, Journal of magnetic resonance imaging : JMRI.
[198] P. Tekkis,et al. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing , 2007, British Journal of Cancer.
[199] Daniel F Hayes,et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[200] J. Bosset,et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[201] H. Ramesh,et al. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. , 2006, Annals of surgery.
[202] Laurence Collette,et al. Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.
[203] R. Heald,et al. Defining the rectum: surgically, radiologically and anatomically , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[204] Catherine Julié,et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[205] A. Benson,et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[206] Robert H Fletcher,et al. Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi‐Society Task Force on Colorectal Cancer and the American Cancer Society * , † , 2006, Gastroenterology.
[207] P. Gibbs,et al. Preoperative Chemoradiation for Rectal Cancer Causes Prolonged Pudendal Nerve Terminal Motor Latency , 2006, Diseases of the colon and rectum.
[208] J. V. van Engelshoven,et al. Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. , 2005, Seminars in ultrasound, CT, and MR.
[209] M. Valerio,et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[210] C. Köhne,et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[211] Y. Atomi,et al. MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma. what is the optimal criterion? , 2004, Anticancer research.
[212] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[213] Bernard Paule,et al. Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.
[214] Myeong-Jin Kim,et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? , 2004, European journal of radiology.
[215] Patrick M M Bossuyt,et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. , 2004, Radiology.
[216] W. Law,et al. Anterior Resection for Rectal Cancer With Mesorectal Excision: A Prospective Evaluation of 622 Patients , 2004, Annals of surgery.
[217] M. Pocard,et al. Treatment of Peritoneal Carcinomatosis From Colorectal Cancer: Impact of Complete Cytoreductive Surgery and Difficulties in Conducting Randomized Trials , 2004, Annals of Surgical Oncology.
[218] D. Sargent,et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[219] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[220] B. Davidson,et al. Strategies to Increase the Resectability of Liver Metastases from Colorectal Cancer , 2003, Digestive Surgery.
[221] H. van Tinteren,et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[222] R. Adam,et al. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[223] R. Newcombe,et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. , 2003, Radiology.
[224] R G Newcombe,et al. Preoperative assessment of prognostic factors in rectal cancer using high‐resolution magnetic resonance imaging , 2003, The British journal of surgery.
[225] L. Schover,et al. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[226] I. Nagtegaal,et al. Circumferential Margin Involvement Is Still an Important Predictor of Local Recurrence in Rectal Carcinoma: Not One Millimeter but Two Millimeters Is the Limit , 2002, The American journal of surgical pathology.
[227] L. Burgart,et al. Risk of Lymph Node Metastasis in T1 Carcinoma of the Colon and Rectum , 2002, Diseases of the colon and rectum.
[228] Rieken,et al. [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[229] H. Kashida,et al. Precancerous lesions of the colorectum , 2001, Journal of Gastroenterology.
[230] U. Mansmann,et al. The prognostic inhomogeneity in pT3 rectal carcinomas , 2001, International Journal of Colorectal Disease.
[231] J. Bond. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps , 2000, American Journal of Gastroenterology.
[232] L. Rutqvist,et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm , 2000, The Lancet.
[233] J. Kruskal,et al. Role of virtual computed tomographic colonography in patients with colorectal cancers and obstructing colorectal lesions , 2000, Diseases of the colon and rectum.
[234] B. Herts,et al. Prospective, blinded comparison of laparoscopic ultrasonographyvs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery , 2000, Diseases of the colon and rectum.
[235] K. Badizadegan,et al. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? , 1999, Diseases of the colon and rectum.
[236] R. Low,et al. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. , 1997, Radiology.
[237] K. Okuno,et al. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. , 1997, Journal of the American College of Surgeons.
[238] S. Cha,et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. , 1997, International journal of radiation oncology, biology, physics.
[239] R. Markert,et al. Is in vivo measurement of size of polyps during colonoscopy accurate? , 1996, Gastrointestinal Endoscopy.
[240] R. Nozaki,et al. Management of early invasive colorectal cancer , 1995, Diseases of the colon and rectum.
[241] P. Quirke,et al. Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer , 1995, The British journal of surgery.
[242] R. Heald,et al. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum , 1994, The British journal of surgery.
[243] T. Minamoto,et al. Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development. , 1993, The American journal of gastroenterology.
[244] L. Bégin,et al. The care of patients with colorectal polyps that contain invasive adenocarcinoma. Endoscopic polypectomy or colectomy? , 1992, Cancer.
[245] J. Newman,et al. Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. , 1989, Gut.
[246] P. Quirke,et al. LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION Histopathological Study of Lateral Tumour Spread and Surgical Excision , 1986, The Lancet.
[247] M. Sivak,et al. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? , 1986, Gastroenterology.
[248] R. Haggitt,et al. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. , 1985, Gastroenterology.
[249] R. Heald,et al. Recurrent cancer after restorative resection of the rectum. , 1982, British medical journal.
[250] C. Morson. The Hampstead General: Beginning and Ending , 1964, British medical journal.
[251] Colorectal Cancer Screening in Average-Risk Adults , 2019, Annals of Internal Medicine.
[252] B. Melosky,et al. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications. , 2018, Archives of pathology & laboratory medicine.
[253] Yuhree Kim,et al. KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases , 2016, Annals of Surgical Oncology.
[254] B. Glimelius,et al. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial. , 2016, European journal of cancer.
[255] P. Gervaz,et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis. , 2015, Future oncology.
[256] M. Wiese,et al. Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[257] Hongbo Zhu,et al. Magnetic resonance imaging in restaging rectal cancer after neoadjuvant chemoradiotherapy. , 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[258] Karin Haustermans,et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. , 2014, European journal of cancer.
[259] Gina Brown,et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[260] K. Bujko,et al. Neoadjuvant radiotherapy (5 × 5 Gy): immediate versus delayed surgery. , 2014, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[261] 김남규,et al. Magnetic resonance imaging in rectal cancer: A surgeon’s perspective , 2014 .
[262] Christophe Laurent,et al. Low Rectal Cancer: Classification and Standardization of Surgery , 2013, Diseases of the colon and rectum.
[263] J. Monson,et al. Practice parameters for the management of rectal cancer (revised). , 2013, Diseases of the colon and rectum.
[264] R. Parks,et al. Perioperative FOLFOX 4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC 40983 ) : long-term results of a randomised , controlled , phase 3 trial , 2013 .
[265] Z. Huan,et al. A comparison between the reference values of MRI and EUS and their usefulness to surgeons in rectal cancer. , 2012, European review for medical and pharmacological sciences.
[266] Heidi Nelson,et al. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. , 2011, International journal of radiation oncology, biology, physics.
[267] V. Arrazubi,et al. Stent or surgery for incurable obstructive colorectal cancer: an individualized decisión , 2009, International Journal of Colorectal Disease.
[268] M. Tatar,et al. Colorectal cancer in Turkey: current situation and challenges for the future , 2009, The European Journal of Health Economics.
[269] Marcin Polkowski,et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. , 2008, The New England journal of medicine.
[270] M. P. Tristan D. Yan BSc,et al. Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis , 2008, Annals of Surgical Oncology.
[271] J. Higginson,et al. International Agency for Research on Cancer. , 1968, WHO chronicle.